evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
19309,GENE_BACKGROUND,,"GSK3B encodes glycogen synthase kinase 3b, a multifunctional serine /threonine kinase found in all eukaryotes. The protein kinase functions as an important regulator of cellular signaling pathways involved in metabolism, cell cycle and proliferation (PMID: 24931005). Unlike most protein kinases, GSK3β is constitutively active in resting cells and undergoes a rapid and transient inhibition in response to a number of external signals. GSK3β activity is regulated by site-specific phosphorylation. Several kinases are capable of regulating the protein kinase including p70 S6 kinase, extracellular signal-regulated kinases (ERKs), p90Rsk, protein kinases A, B and C, and MEK1/2 (PMID: 12615961, 11527574, 16935409, 11394906, 15020233). Dysregulated GSK3B has been implicated in the development of a number of human diseases such as diabetes, cardiovascular disease, neurodegenerative diseases and bipolar disorder (PMID: 12615961, 11527574, 16935409). Overexpression of the protein kinase has also been implicated in tumorigenesis and cancer progression including ovarian, colon, liver and pancreatic carcinomas (PMID: 16556076, 17912008, 11883528, 16556076, 16342409, 18606491). Several GSK3β inhibitors have been studied in preclinical trials, for example pharmacological inhibitors suppress proliferation of the ovarian cancer cells in vitro and prevents the formation of tumors in nude mice generated by the inoculation of human ovarian cancer cells (PMID: 16788573).",,2017-01-17,,2932,GSK3B,glycogen synthase kinase 3 beta,False,ENST00000316626,NM_002093.3,False,16788573,Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.,Cell research,2018-07-01T20:06:00,16,7,671-7,Cao Q et al,,,0001-07-01,,12615961,GSK-3: tricks of the trade for a multi-tasking kinase.,Journal of cell science,2018-04-01T20:03:00,116,Pt 7,1175-86,Doble BW et al,,,0001-04-01,,16342409,CK2 as a positive regulator of Wnt signalling and tumourigenesis.,Molecular and cellular biochemistry,2018-06-01T20:05:00,274,2001-01-02,1963-07-01,Seldin DC et al,,,2002-01-02,,18606491,Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.,Cancer letters,2018-01-18T20:09:00,273,2,194-200,Luo J,doi: 10.1016/j.canlet.2008.05.045,,2018-01-18T02:00:00,,17912008,Primers on molecular pathways. The glycogen synthase kinase-3beta.,Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],2007,7,2001-05-06,398-402,Billadeau DD,,,2018-05-06T04:02:00,,16935409,The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.,Progress in neurobiology,2018-07-01T20:06:00,79,4,173-89,Beurel E et al,,,0001-07-01,,11883528,Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.,Advances in cancer research,2002,84,,203-29,Manoukian AS et al,,,Manoukian AS et al. Advances in cancer research. 2002;84()203-29.,,11527574,The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.,Progress in neurobiology,2018-11-01T20:01:00,65,4,391-426,Grimes CA et al,,,2018-11-01T04:26:00,,11394906,Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.,Biochemical and biophysical research communications,2018-06-08T20:01:00,284,2,485-9,Hartigan JA et al,,,0001-06-08,,16556076,Targeting GSK-3: a promising approach for cancer therapy?,"Future oncology (London, England)",2018-02-01T20:06:00,2,True,91-100,Ougolkov AV et al,,,2018-02-01T01:00:00,,24931005,GSK-3 as potential target for therapeutic intervention in cancer.,Oncotarget,2018-05-30T20:14:00,5,10,2881-911,McCubrey JA et al,,,2018-05-30T09:11:00,,15020233,Glycogen synthase kinase-3beta is tyrosine-phosphorylated by MEK1 in human skin fibroblasts.,Biochemical and biophysical research communications,2018-04-02T20:04:00,316,2,411-5,Takahashi-Yanaga F et al,,,0001-04-02,
19308,GENE_SUMMARY,,"GSK3B encodes a serine/threonine kinase involved in the regulation of insulin-dependent glycogen synthesis. Overexpression of GSK3B is found in ovarian, colon, liver and pancreatic cancers.",,2017-01-17,,2932,GSK3B,glycogen synthase kinase 3 beta,False,ENST00000316626,NM_002093.3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
